Clinical trial

ALG-LungCancerRegistry (SAFRO2202)

NCT07161882

StatusRECRUITING

Study typeOBSERVATIONAL

Start date2025-06-01

PhaseN/A

Study timeline

Study start (actual)2025-06-01Date precision: day

Registry last updated2025-09-16

Observed by CureCurrent2026-10-07

Recorded dates are source observations, not predictions. Missing milestones are not estimated.

Conditions

Lung Neoplasmsunresolved

Carcinoma, Non-Small-Cell Lungunresolved

Carcinoma, Small Cellunresolved

Carcinoid Tumorunresolved

Interventions

Observational Data CollectionOTHER

Sponsors & collaborators

Société Algérienne de Formation et de Recherche en Oncologielead sponsor

AstraZenecacollaborator

Registry source

Open the source record to verify current eligibility, contacts, locations and registry updates.

Open NCT07161882 on ClinicalTrials.gov ↗

Registry-derived research relationships: ClinicalTrials.gov. Raw condition and intervention labels remain distinct from canonical MONDO/RxNorm entities unless separately normalized.